“EVALUATION OF EFFICACY OF PROPHYLACTICALLY USED PREMEDICATION FOR THE MANAGEMENT OF NAUSEA, VOMITING AND HYPERSENSITIVITY REACTIONS TO CISPLATIN, TAXANES AND FAC (5-FLUOROURACIL, ADRIAMYCIN (DOXORUBICIN) AND CYCLOPHOSPHAMIDE) BASED CHEMOTHERAPY:”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 9, Sept. 2024, pp. 769-76, https://doi.org/10.53555/y6s67361.